China Pharma Holdings Inc. (CPHI)
NYSE · Healthcare
China Pharma Holdings Inc. Operating Income 2010–2025
China Pharma Holdings Inc. annual/quarterly operating income history and growth rate from 2010 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- China Pharma Holdings Inc. operating income for the quarter ending March 31, 2026 was -1.1 M, a 47.28% increase year-over-year.
- China Pharma Holdings Inc. operating income for the twelve months ending March 31, 2026 was -3.2 M, a 23.14% decrease year-over-year.
- China Pharma Holdings Inc. annual operating income for 2025 was -3.2 M, a 29.41% decrease from 2024.
- China Pharma Holdings Inc. annual operating income for 2024 was -4.6 M, a 66.76% increase from 2023.
- China Pharma Holdings Inc. annual operating income for 2023 was -2.8 M, a 22.46% decrease from 2022.
- China Pharma Holdings Inc. annual operating income for 2022 was -3.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
China Pharma Holdings Inc. Operating Income — FAQ
China Pharma Holdings Inc. (CPHI) operating income over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is China Pharma Holdings Inc.'s operating income?
China Pharma Holdings Inc. (CPHI) reported operating income of -$3M for fiscal 2025.
Where can I see CPHI's operating income history?
The chart and table above show China Pharma Holdings Inc.'s operating income by year and by quarter, including the growth rate.